Hypophosphatasia Market Report
The 7 major hypophosphatasia markets reached a value of US$ 725.0 Million in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 1,036.4 Million by 2034, exhibiting a growth rate (CAGR) of 3.3% during 2024-2034. The escalating prevalence of somatic mutations in genetic materials, which can result in impaired bone mineralization and abnormal tooth development, is primarily driving the market.